Radiation Oncology/Therapy: Page 21

IBA receives 1st payment from Chinese licensing deal

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has received the first payment of 20 million euros from its strategic licensing deal with CGN Nuclear Technology Development in China.

September 23, 2020

600+ km trek across the Himalayas for cancer therapy

By Tirthraj Adhikari

It takes on average 18 hours by bus for patients to reach the cancer hospital in Nepal, and many of them travel over 600 km. Now the pandemic has made it even more difficult to get treatment, writes Tirthraj Adhikari, a medical physicist trained in Italy. He gives a personal account of the challenges faced by patients and staff.

September 22, 2020

Cerveau forms science advisory board

By AuntMinnieEurope.com staff writers

Radiopharmaceutical developer Cerveau Technologies has formed a scientific advisory board made up of chemistry, biology, and medicine experts in Alzheimer's disease.

September 20, 2020

Belgian hospital begins using IBA proton system

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications announced that the Particle Therapy Interuniversity Center Leuven in Belgium has begun treating patients with the company's ProteusOne system.

September 16, 2020

Q BioMed reports sales progress with Strontium89

By AuntMinnieEurope.com staff writers

Biotech company Q BioMed is reporting sales progress from the launch of its Strontium89 (strontium-89 chloride injection) metastatic bone cancer palliation radiopharmaceutical.

September 14, 2020

Germany orders 1st Ethos therapy system

By AuntMinnieEurope.com staff writers

The German Cancer Research Center in Heidelberg has ordered Germany's first Ethos radiation therapy system from Varian Medical Systems.

September 10, 2020

Median highlights research on iBiopsy platform

By AuntMinnieEurope.com staff writers

Imaging software developer Median Technologies said that its iBiopsy platform has shown promising results in measuring antitumor immune response, potentially helping to identify patients who are responding to treatment.

September 8, 2020

Post-treatment SPECT/CT monitors radionuclide dose

By Kate Madden Yee

A research group from the Peter MacCallum Cancer Center in Melbourne, Australia, has pioneered a technique that uses a follow-up SPECT/CT examination after radionuclide therapy to personalize the radiation dose delivered to a patient.

September 6, 2020

Siemens raises 2.7B euros to fund Varian acquisition

By AuntMinnieEurope.com staff writers

Siemens Healthineers has raised 2.73 billion euros in capital to fund the company's acquisition of Varian Medical Systems, a deal that was announced in August.

September 2, 2020

German investigators highlight clinical value of PET/MRI

By Rebekah Moan

In a study of more than 1,000 examinations, German researchers found that PET/MRI improved lesion detection by over 15% compared with PET/CT in malignant bone disease and lung cancer. Also, PET/MRI reduced ionizing radiation by nearly 80% when compared with PET/CT.

September 2, 2020

IBA secures large proton therapy contract in China

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has received a contract from the Sichuan Cancer Hospital and Institute in China to install its ProteusPlus proton therapy system.

August 31, 2020

ViewRay launches radiation treatment access scheme

By AuntMinnieEurope.com staff writers

Image-guided radiation therapy vendor ViewRay, cancer services provider GenesisCare, and the University of Oxford in the U.K. have launched a project designed to provide free access to radiation therapy for National Health Service (NHS) patients with localized pancreatic cancer.

August 30, 2020

Previous Page

Page 21 of 126

Next Page